►
From YouTube: American Cancer Society Research Breakfast
Description
Significant breakthroughs in cancer detection and treatment have been made over the last ten years, with the help of organizations like the American Cancer Society Cancer Action Network. Mayor Walsh joins medical professionals and cancer research advocates at the organization's annual breakfast at the State Room in the Financial District, to thank ACS CAN for protecting the needs of cancer patients and their families.
A
A
C
A
C
A
A
Morning,
a
lot
of
ground
to
cover
the
next
hour
as
you'll,
hear
drill
requisite
American
Cancer
Society
can
is
making
a
bold
compelling
calls
Americans
across
the
country,
the
average
age,
their
elected
officials,
about
the
importance
of
cancer
research
as
a
national
priority,
and
thanks
to
your
support,
we
have
made
a
good
deal
of
progress
to
continue
to
inspire
that
progress.
We
are
very
fortunate
to
have.
Are
we
fortunate
to
have?
Is
the
mayor
here.
A
A
A
C
A
He
is
director
of
Mass
General,
Cancer
Center
and
we'll
also
hear
from
a
local
survivor
who
can
speak
firsthand
about
the
importance
of
the
work
being
done
by
cancer
researchers
across
the
country.
We
will
wrap
up
our
morning.
Recognizing
a
family
leadership
and
philanthropic
commitment
has
helped
improve
cancer.
Fighting
efforts
across
the
Commonwealth
and
beyond.
So
we're
going
to
get
started
and
I
haven't
asked
to
ask
you
to
fish.
Your
phones
to
Bonnie
Raitt
not
be
presenting.
A
C
E
To
be
here
and
on
behalf
of
American
Cancer
Society,
it
is
my
true
pleasure
to
welcome
you
to
the
10th
annual
American
Cancer
Society
Cancer
Action
Network
New
England
Research
breakfast
I'd,
like
to
start
by
thanking
our
incredible
volunteer
leaders
who
helped
create
this
amazing
morning.
So
let
me
start
with
dr.
mark
Goldberg,
dr.
support.
E
March
is
the
chair
for
our
breakfast
asperity
is
an
incredible
volunteer
with
us.
He
currently
serves
on
the
American
Cancer
Society
wingman
Board
of
Directors,
as
well
as
during
this
event.
So
thank
you
so
much
Mark
for
your
leadership.
Our
record
council
also
includes
leaders
from
across
Massachusetts
from
the
Massachusetts
economy
and
healthcare
sectors,
banking,
our
architecture,
firms
and
healthcare
systems.
So
I'd
like
to
invite
the
members
of
the
ACS
can
research
breakfast
councils,
you
can
all
stand
so
we
can
thank
you
and
salute
you
for
your
commitment
in.
E
E
Face
when
Dennis
Cataldo
is
dr.
demian
Rosenthal,
so
thank
you
for
joining
us.
I'd
also
like
to
recognize
and
thank
I,
think
to
safety
issues
from
our
national
board
of
directors
of
ATF
can
who's
here
today.
So
sandy
good
morning.
Thank
you
for
joining
us
as
well
as
Christian
with
our
executive
vice-president
for
the
Northeast
region
of
the
American
companies,
the
Crusaders
deserving
of
resolve.
E
E
In
Canada
professionals
with
us
this
morning,
these
heard
from-
and
we
are
so
proud
to
invest
in
these
researchers
and
hope
steadfast
the
belief
that
their
knowledge,
passion
and
determination
will
lead
to
improved
outcomes
for
all
individuals
affected
by
cancer,
so
informative.
We
could
ask
the
ACS
funded
grant
recipients
to
if
you
could
all
stand.
So
we
can
recognize
you
and
thank
you
for
your
work.
E
E
B
E
We're
also
proud
that
last
year
the
American
Cancer
Society
announced
our
commitment
to
double
our
annual
investment
in
funding
for
the
coming
year,
which
means
that
moving
forwards
in
society
will
each
year
add
about
a
quarter
of
a
billion
dollars
to
our
research
funding.
To
find
even
more
investigators
like
the.
E
E
E
Can
a
Twitter
account
so
give
me
a
second
here,
take
a
picture
of
all
of
you
and
this
amazing
turn
on
we
have
this
morning.
So
thank
you
again
for
spending
the
morning
with
us.
Thank
you
for
georgians
need
continued
commitment
to
cancer
research
funding
and
it
is
now
my
pleasure
to
introduce
Chris
Hanson
Christmas
of
president
of
80s
cans,
he's
headquartered
in
Washington
DC,
and
he
leads
a
staff
team
around
250
and
thousands
of
volunteers
that
every
single
congressional
district
across
the
country
that
advocates
for
policies
to
increase
research
funding
so
welcome
good.
G
G
G
The
success
that
we're
having
is
because
of
you
is
because
of
the
support
we
have
from
everybody
like
you
and
us
also
from
the
support
we
have
from
people
Republican
when
we
were
me
to
holding
on
the
issues
that
we
were
gone,
the
public
supports
us
and
everything
we
do
all
the
time.
So
it's
really
an
exercise
in
democracy,
cancer
tastes,
the
life
of
one
person
in
this
country
every
minute
of
every
day.
G
G
Just
cancer
pace
the
life
of
one
person
in
this
country
every
minute
of
every
day.
The
reason
that
we're,
even
that
even
is
we're
making
tremendous
progress
and
creating
more
cancer
survivorship.
That
is
the
axilla
case,
and
it's
still
a
case
because
of
the
increase
in
incidence
of
cancer
because
of
the
aging
population.
So
we
are
making
tremendous
progress,
but
we
can't
stop.
C
G
We
work
the
increase
in
sustained
federal
and
government
and
state
and
federal
government
investments
in
cancer
research,
improving
access
to
care,
strengthening
tobacco
control
and
also
helping
patients
have
a
better
quality
of
life.
You
spend
a
lot
of
time
and
we've
got
a
big
coalition.
We
don't
value
to
care,
trying
to
give
people
palliative
care
from
the
point
of
diagnosis
on
for
people
that
had
serious
illnesses
like
cancer,
so
that
they
have
a
politic
life.
The
good
news
is
that
there
are
more
more
cancer
survivors,
so
sustaining
that
quality
of
life
is
very
important.
G
What
makes
ACS
and
different
and
I
would
say
that
it's
the
sheer
force
of
our
sophisticated,
well-trained,
effective,
volunteer
member
when
a
lot
of
them
in
this
room,
a
lot
of
them
that
help
create
this
event
made
up
of
patients
survival
as
caregivers
experts,
lawyers
and
business
people.
We
have.
We
have
four
types
of
people
and
more
capability
in
earth
and
our
grassroots
network
that
you
can
imagine
and
we
we
work
through
coordinated
activity
in
every
congressional
district
in
the
country.
G
We
have
a
volunteer
leader
in
every
state
in
the
country
and
we
have
a
volunteer
leader
and
every
congressional
district
in
the
country,
and
we
have
grassroots
into
that.
And
then
we
have
wonderful
people
from
all
the
communities
that
are
represented
here
today
that
help
us.
We
also
are
supported
by
professionals,
policy
professionals,
government
relations
professionals
and
then
we
because
we
know
contributing
political
money,
anybody
we
we
do
things
like
in
addition
to
our
grassroots.
G
B
G
B
G
Going
to
come
out
of
it,
but
it's
very
important
and
whether
it's,
whether
it's
really
ultimately
going
to
be
a
repeal
of
the
Affordable
Care
Act,
or
whether
it's
going
to
actually
turn
out
to
be
something
that
they
call
a
repeal
of
the
Affordable
Care
Act.
But
it's
actually
a
fixing
of
the
Affordable
Care
Act.
We're
not
sure.
But
it
has.
G
Because
of
the,
if
they
have
a
repeal
bill,
it
has
passed
the
Senate
by
June
30th
and
then
basically
gives
the
Congress
one
month
before
the
August
recess,
to
merge
the
House
and
Senate
bills
and
to
get
something
done.
This
is
very
important
because
patients
need
to
care
patients
need
the
insurance.
One
of
the
things
that
we're
working
on
is
trying
to
preserve
critical
patient
protections,
prohibiting
discrimination,
patient
health,
history
banning
annual
and
lifetime
insurance
coverage
limits,
guaranteeing
access
to
essential
health
benefits,
regardless.
G
Unfortunately,
a
flat
credit
along
with
Medicaid
cuts
would
greatly
limit
the
ability,
millions
of
people
who
are
for
the
access
to
the
healthcare
that
they
need,
and
we
know
from
any
number
of
studies
that
we've
been
done.
People
are
that
appropriately
insured.
The
cancer
outcomes,
not
surprisingly,
are
far
worse.
It's
discovered
at
a
part,
later-stage
harder
to
treat
more
expensive
to
treat
more
painful,
more
appreciative
for
the
patient,
so
we
are
working
to
prevent
that
kind
of
a
situation.
G
G
To
prevent
continuous
coverage
requirements
that
can
wind
up
actually
discriminating
against
those
who
can't
afford
due
to
illnesses
like
cancer
or
who
have
to
take
a
lead
to
care
for
a
loved
one
who
has
cancer
and
so
we're
trying
to
make
sure
that
we
don't
do
something
that
accidentally
hurts
a
lot
of
people.
I
have
to
commend.
The
leaders
in
Massachusetts,
governor
Baker,
has
led
advocacy
for
Medicaid
funding
for
the
state.
I
salute
his
leadership
in
this
area.
Mayor
Walsh
has
been
a
leader
in.
G
G
B
C
G
Control
programs,
which
would
also
eliminate
the
Yanis
of
smoking
in
health
in
the
CDC,
which
would
be
a
very
bad
thing
to
do
so.
We
are
responding
with
our
with
our
loving.
We
are
leading
a
coalition
called
on
boys
against
cancer,
mobilizing
our
grassroots
all
across
the
country.
We
have
our
social
media
campaigns
that
are
going
on.
I
just
want
to
mention
the
fact
that
we're
also
part
of
a
an
organization
called
United
for
medical
research,
and
there
are
people
sitting
in
this
room
that
are
involved.
G
C
G
G
Massachusetts
how
we
are
pressing
for
the
passage
of
youth
tobacco
prevention
bill
here
in
Massachusetts,
we've
had
a
number
of
events
working
on
that
our
state's
annual
Lobby
Day
in
tobacco-free
Massachusetts
coalition,
Lobby
Day,
we're
also
particularly
focused
on
a
t21
as
spective,
is
diligent
prohibiting
the
sale
of
tobacco
to
people
that
are
under
the
age
of
21,
and
we're
very
pleased
that
Governor
Baker
has
publicly
supported
the
bill.
I
am
going.
A
A
And
we're
also
joined
today
by
Morgan
bells,
a
representative
from
congressman
Sentinels
office.
So
thank
you
both
for
being
here
soon
now.
I'd
leave
to
introduce
a
good
friend
of
the
American
Cancer,
Society
and
ACS
can
Gary's
Azula
was
president
and
managing
director
of
EMV.
Sir
oh
did
I.
Do
it
right?
Salva
Gary
has
played
a
key
role
in
the
advancing
and
supporting
the
great
work
that
is
done
every
day
at
me
and
Ichiro
no
to
help
fight
cancer.
A
H
G
H
H
It
stood
with
ACF
can
and
the
muscly
and
dialoguing
actually
so
relentlessly
drive
for
a
decade
for
10
years.
So
it's
really
amazing
and
strong
commitment.
Part
of
the
company,
the
voices
that
Asians
can
brings
to
the
hill
and
Eddy
State
House
around
the
country,
are
really
critical.
Without
the
grassroots
presence
to
remind
regulators
about
the
true
needs
of
real
life,
people
living
with
cancer,
we
wouldn't
be
where
we
are
today
and
we
couldn't
truly
move
forward
in
our
fight
against
cancer.
H
H
Today
and
the
support
of
everyone
in
this
room
and
beyond
are
an
important
step
in
making
breakthroughs
and
ganzar
possible
I
want
to
wish
a
special
thank
you
to
Chris
Hampton
and
his
entire
team.
The
organization's
commitment
and
privates
are
putting
together
important
rallying
points
like
today's
event
here
this
morning
in
this
beautiful
venue.
So
thank
you
for
letting
us
be
part
of
it.
We
will
continue
to
stand
beside
all
of
you
and
our
collective
mission
and
cancer.
Thank
you
and
have
a
great
morning.
A
To
dr.
Daniel,
Hebert
who's,
the
director
of
Mass
General,
Hospital,
Cancer
Center
and
the
Curt
I
never
got
a
good
pronounce
to
pronounce
her.
For
this
is
a
law
firm,
fabulous
professor
of
oncology
at
Harvard,
Medical
School,
dr.
Hebert,
has
long
hits
a
long
history
of
accomplishments
in
cancer
research.
Here
in
Boston,
he
completed
his
medicine
residency
at
MGH,
Clinical,
Oncology
training
at
the
Dana
Farber
postdoctoral
research
at
MIT
before
joining
the
MGH
and
Harvard
faculty
in
t91.
A
I
I
For
the
invitation
to
speak
this
morning,
only
the
American
Cancer
Society
can
get
some
of
the
exceptional
people
to
get
up
so
exceptionally
early
in
the
morning,
but
seriously
the
breadth.
The
depth
and
the
impact
of
ACS
is
palpable.
This
morning
with
soon
the
mayor
of
Boston,
sharing
this
breakfast
meeting
with
so
many
health
care
providers,
clinicians
scientists
active
advocates
representing
our
entire
community.
As
you
know,
ACS
is,
and
has
always
been
the
most
powerful
and
long-standing
advocate
for
cancer
care.
In
for
cancer,
research
in
the.
I
Acs
focused
on
supporting
young
faculty
and
our
Boston
institutions
have
had
a
very
real
impact
in
sustaining
a
research
enterprise,
that's
the
envy
of
the
world
and
which
is
widely
appreciated
as
one
of
those
trademarks
of
Boston
we
do
seem
to
be
living
in
an
increasingly
complicated
time
and
ACS
is
exceptional
in
bringing
together
a
blend
of
science
and
social
action,
discovery
and
advocacy
that
are
needed
to
bring
us
together
and
move
the
field
forward.
As
cancer
researchers
we
live
in
a
paradox.
I
B
I
Cancer
are
living
longer
with
better
more
focused
treatments
and
better
quality
of
life
and
in
cancer
research
labs
throughout
Boston
in
the
world.
There's
a
constant
hum
of
energy
and
excitement
about
the
promise
and
ongoing
to
yet.
At
the
same
time,
federal
funding
continues
to
drop
and
we're
now
starting
to
see
the
long-term
consequences
with
fewer
trainees,
choosing
a
career
in
research
and
promising
research
faculty,
even
in
our
very
own
elite
Boston
institutions
just
struggling
to
stay
afloat.
The.
C
B
I
I
I
I
But
the
side
effects
can
involve
inflammation
in
normal
organs
as
well
and
there's
a
real
need
for
biomarkers
that
predict
which
patient
will
respond
and
which
will
not
benefit
and
for
new
strategies
to
extend
the
effectiveness
of
these
treatments
to
cancers
where
the
immune
system
just
doesn't
seem
to
recognize
the
tumor,
but
I'm
here
really
I
really
want
to
talk
about
wave
number
three
and
that's
the
concept
of
early
detection
of
cancer
with
the
goal
to
diagnose
invasive
cancers
before
they
metastasize
or
before.
There's
so
many
cancer
cell.
I
That
resistance
to
County
to
anti-cancer
drugs
becomes
preordained
by
the
way,
I'll
admit
I
kind
of
made
up
the
terminology
of
waves.
So
please
don't
look
it
up
anywhere
and
wave.
Three
is
not
yet
officially
recognized
by
ACS
or
any
other
official
body
and
that
matters
but
I
happen
to
believe
in
it
and
I
wanted
to
share
with
you
this
morning.
We
all
know
of
rare
patients
who
had
a
potentially
lethal
lung
or
pancreatic
cancer
that
was
diagnosed.
I
I
We
also
know
that
some
therapies,
like
the
breast
cancer
drug
Herceptin,
have
relatively
modest
and
transient
benefit
when
given
to
women
with
advanced
metastatic
breast
cancer,
but
it's
curative
when
given
early
in
the
adjuvant
setting
to
women
who
just
had
a
primary
breast
cancer
removed.
So
why
is
that?
If
you
imagine
that
there
are
billion
cancer
cells
in
the
body,
it's
likely
that
some
of
them
will
be
resistant
to
any
treatment.
That's
given
no
matter
how
good,
but
if
there
are
only
a
million.
B
I
I
X-Rays
like
mammograms
or
low-dose
cat
scans
of
the
run
and
lots
of
tall
positives,
and
you
can
chase
many
shadows
for
every
cancer.
That's
picked
up
or
cancers
can
arise
in
between
the
yearly
x-rays.
Blood
tests
like
PSA,
go
up
with
aging
and
they're,
not
so
good,
at
distinguishing
between
aggressive,
prostate
cancers
that
are
lethal
or
indolent
prostate
cancers
that
you
should
just
lead
alone,
and
this
is
where
I
believe
we're
poised
for
a
new
revolution
in
cancer
diagnostics,
deploying
the
full
power
of
molecular
biology
to
the
early
detection
of
cancer.
I
There
are
new
approaches,
many
new
approaches
that
are
in
development,
from
blood
tests
to
urine
tests,
imaging
tests
and
personally
I'm
most
excited
about
strategies
to
look
for
signs
of
in
the
blood
cancers
can
shed
cells
into
the
blood
from
the
very
first
time
to
become
invasive.
They
shed
fragments.
I
Blood
they
can
shed
cellular
fragments
and
the
new
power
of
sequencing
and
genetic
analysis.
This
we
can
detect
infinitesimal
traces
of
these
cancer
cells
and
cancer
products
in
the
blood.
The
signal
can
be
very
small,
almost
like
cosmic
rays
from
some
distant
planets,
but
their
clarity
and
the
specificity
are
more
powerful
than
anything
we've
ever
had
before.
Now,
we're
obviously
not
there
yet,
but
you
can
see
it
coming,
and
these
are
the
kinds
of
technologies
that
together,
I
believe
will
revolutionize
the
way
we
diagnose
cancer
and
therefore
the
way
we
treat
cancer
so.
I
Would
happen
if
we
did
have
a
singular
blood
test
or
panel
of
tests
that
would
enable
us
to
diagnose
the
earlier
stage
of
a
lethal
cancer
and
potentially
make
it
curable.
Well,
first,
we
need
the
clinical
trials
to
prove
it.
Typically,
these
are
done
with
large
scale
studies
and
people
who
have
increased
risk
or
somehow
predisposed
to
developing
a
particular
cancer.
C
I
Know
in
our
society
we
reimburse
and
currently
reimburse
very
well
for
drug
therapies
and
for
medical
interventions,
but
we
don't
pay
very
much
for
diagnostic
tests.
That
would
help
us
tell
who
benefits
from
the
treatment
or
who
might
have
an
early
cancer.
So
for
clinical
research
on
early
detection
and
intervention
to
thrive,
that's
a
model
that
may
have
to
change.
I
The
other
thing
is
the
endpoint,
for
our
current
clinical
trials
is
whether
the
tumor
shrank
or
whether
a
patient
with
cancer
survive
longer
in
the
future.
The
more
difficult
end
coin
may
have
to
be
what's
a
lethal
but
curable
cancer
detected,
and
was
it
successfully
treated
and
also
in
our
specialized
cancer
centers.
We
typically
wait
for
patients
to
be
diagnosed
with
cancer
because
they
have
pain,
no
symptoms,
and
then
we
offer
them
treatment.
I
How
would
medical
practice
change
if
we
actually
have
the
tools
to
screen
for
early
invasive
cancers?
The
critical
Commission's
would
then
be
the
primary
care
providers.
Not
the
oncologists,
perish
that
thought
they
would
need
to
integrate.
Calculations
of
cancer
risk
for
the
appropriate
screening
tests
and
the
tests
would
have
to
reliably
distinguish
between
indolent
and
invasive
cancers.
I
I
I
Someone
who's
not
here
with
us
today,
but
who's
very
much
embedded
within
the
vision
that
I
just
outlined.
The
men
were
planning
on
honoring.
Today,
Henry
Tamir
died
tragically
a
few
weeks
ago
and
you'll
hear
more
about
him
later
this
morning
from
dr.
mark
Goldberg,
when
I
was
first
invited
to
give
this
talk,
Henry
and
I
was
supposed
to
speak
one
after
the
other.
We
got
together
to
review
our
speaking
points
and
we
had
long
been
a
pioneer
in
precision
medicine.
I
I
I
A
Thank
you,
dr.
Hebert,
you're,
clearly
passionate
in
your
fight
against
cancer
and
give
us
important
reasons
why
we
need
to
continue
to
fight
for
funding
for
the
NCI
and
for
the
NIH
in
general
to
continue
this
exponential
growth
and
diagnosis
and
treatment
that
we've
seen
in
the
past
ten
years.
So
thank
you
for
laying
that
out
for
us.
You
see
the
mayor
is
here:
I
hope
you
had
a
little
time
to
snark
down
some
food,
but
it
doesn't
look
like
you
did.
B
B
Cancer
Society
feel
great
work.
Thank
you
very
much,
I'm
honored
to
be
here
today,
two
other.
Thank
you.
Dr.
Hamburg
was
great
to
hear
you
talking.
We
look
forward
to
the
day
when
we
do
have
the
treatment
for
cancer
and
I
know
this
I.
On
my
way
here
today,
I
was
talking
to
a
brother
of
a
firefighter
who
was
going
into
Mass
General
today
to
have
prostate
cancer
surgery
when
you
think
about
every
day,
in
our
job
and
in
the
fire
department.
B
It's
a
constant,
constant
struggle,
constant
conversation
around
cancer
and
it
seems
like
wherever
we
go.
That's
the
diet,
that's
the
conversation.
We
have
a
lot
of
ways
so
I
want
to
thank
you
and
everyone
in
your
field
for
the
great
work
you're
doing
here
in
Boston
in
the
country
in
the
world.
I
also
want
to
recognize
Len
Peters
who's.
Here,
thank
you
for
for
being
here,
bilenda
and
Adriana.
Thank
you
as
well.
You
know,
you
certainly
a
part.
B
B
Has
made
this
only
Azzam,
yet
thank
you
for
being
in
this
morning
with
us
as
well.
I
want
to
thank
I'm
filter.
Roto
chief
village
arose
with
us
as
well
friend,
from
health
Human
Services
in
the
city
of
Boston,
for
all
the
great
work
that
Felix
does
in
public
health
is
under
his
cabinet,
and
so
we're
constantly
talking
about
issues
and
and
how
do
we
make
life
better
and
healthy
for
people
of
Boston
Boston
Bostonians,
look
around
the
showman
is
miracle
workers.
I
want
to
thank
the
entire
board
of
the
ACA.
B
B
Your
vocal
advocates
the
cancer
patients,
your
visionaries
in
improving,
certainly
the
cancer
prevention,
something
that's
important,
as
was
said
earlier,
you're
the
warriors
fighting
for
equal
access
and
help
to
help
you
cancer
research
to
some
of
the
most
important
work
of
our
time.
These
activities
are
certainly
harder
and
miracles
that
change
lives
and
then
change
in
the
course
of
history.
As
I
said
earlier,
I
was
diagnosed
with
Burkitt's
lymphoma
at
the
age
of
seven.
My
mother
took.
C
B
When
they
got
there,
they
sent
me
home
the
first
night.
They
weren't
quite
sure
what
was
next.
Then
they
went
back
again.
I
was
tired.
It
was
those
just
sleeping
all
day
all
the
time
and
she
brought
me
back
in
and
they
found
out
that
they
had
vertical
foam
and
they
gave
my
mother
in
1974
two
options.
B
B
Second
option
and
my
parents
took
the
second
option,
thanks
to
both
treatments
being
developed
at
the
time.
At
that
time,
I
survived,
I
was
able
to
realize
my
dream
is
being
near.
The
city
of
Boston
I've
had
an
incredible
life
because
of
that
because
of
the
kinds
of
research
that
ACA
is
driving
for
I'm
standing
here
today
because
of
a
lot
of
people
in
this
room,
since
that,
since
that
time
in
1974,
when
I
had
cancer
treatment
and
Prevention
has
come
a
long
long
way.
B
Certainly,
when
you
sit
down
and
talk
about,
you
think
about
74
to
2017
the
motor-boat
era,
the
morality
rates
have
been
declining
since
the
early
90s,
thanks
in
large
part
to
the
natural
institution
of
Health.
Nih
funding
supports
cutting-edge
research
taking
place
at
universities.
Cancer
centers
here
in
Massachusetts
Boston
received
1.85
billion
dollars
from
NIH
last
year
alone.
This
funding
just
is
in
saving
lives.
B
It's
also
making
our
growth
in
the
life
science
sector
to
be
able
to
look
at
new
cures
and
new
treatments
for
other
diseases,
certainly,
and
it's
helping
the
biotech
industry
as
well.
The
white
house
has
proposed
an
18
percent
cut
to
those
funds.
It
was
about
a
300
million
dollar
cut
to
the
city
of
Boston,
we're
urging
Washington
to
see
scientific
and
economic
promise
as
work.
B
They
work
together,
we're
urging
them
to
consider
the
real
cuts
that
will
hurt
people
in
her
research
and
have
had
progress
as
we
move
forward
here,
but
no
matter
what
happens
in
Washington
and
I
do
feel
confident
that
we'll
be
able
to
to
win
that
fight
in
Washington,
but
no
matter
what
happens
in
Washington.
We
know
that
the
American
Cancer
Society
will
continue
to
drive
the
progress.
B
In
the
United
States
of
America,
it's
going
to
continue
to
develop
new
cures,
save
lives,
push
the
limits
of
what
we
think
is
possible.
I
want
to
thank
the
American
Cancer
Society
for
believing
in
the
power
of
science
and
investing
in
the
health
of
all
Americans
I
want
to
thank
all
of
you
today
to
support
this
vital,
life-saving
work
and,
in
particular,
I
want
to
thank
the
Massachusetts
chapter.
I
want
to
thank
all
the
board
members
that
are
here.
I
know
someone
might
be
Dennis
Cataldo
down
there.
B
One
day
you
Dennis,
they
could
feel
great
work
and
I
know
Dennis
the
cancer
survivor,
and
so
many
other
folks
in
this
room
have
done
that
work.
So
I
truly
want
to
thank
you
for
it.
As
mayor
of
the
city
of
Boston,
do
you
have
a
when
look
at?
What's
going
on
it's
a
little
bit
of
a
different
obligation?
B
I
remember
when
I
first
got
elected
to
the
House
of
Representatives
and
a
couple
years
later,
Felix
got
elected
to
the
City
Council
and
we
were
talking
of
high
tech,
high
cancer
rates
in
the
communities
of
color,
and
we
were
watching
on
hospitals.
Do
some
work
around
their
dana-farber
and
Children's
Hospital
and
some
of
the
other
hospitals
in
the
long
run
medical
area,
it's
important
for
us
not
to
stuff
our
work.
Now,
it's
not
it's
not
time
to
slow
our
work
down.
B
A
We
now
get
to
hear
a
first-hand
account
as
to
why
what
you've
heard
so
far
this
morning
is
critically
important.
Next
up
is
Lynn
Peters,
a
cancer
survivor.
In
a
long
time,
ACS
can
volunteer
and
passionate
advocate
for
cancer
research
funding.
Please
welcome
to
the
podium
lynn
peters,
to
share
her
powerful
and
personal
story.
D
Good
morning
so
I'm
here
to
tell
you
about
my
relationship
with
the
American
Cancer
Society
on
April
20th
1995
on
my
father's
58th
birthday,
I
listened
to
a
doctor
say
your
father
has
pancreatic
cancer
and
lung
cancer.
They
gave
him
an
estimated
six
months
to
live.
On
June,
15
1995,
my
father
died
and
on
Father's
Day.
That
year
went
to
its
funeral
for
a
couple
of
years.
After
that,
I
was
extremely
lost.
My
dad
had
been
my
best
friend
my
mentor.
He
taught
me
how
to
take
care
of
myself.
He
taught
me
how
to
dance.
D
He
taught
me
how
to
use
a
slide
roll.
He
was
an
amazing
man
and
I.
Just
I
was
having
a
hard
time.
Without
him,
I
went,
helpless,
I
felt
hopeless
and,
quite
honestly,
I
was
in
a
very
dark
place.
In
my
life.
He's
been
my
rock
and
I
just
didn't
know
how
to
get
along
without
him.
When
somebody
asked
me,
would
you
join
me
and
be
a
member
of
my
team
for
Relay
for
Life
and
I
said:
okay,
I
didn't
attend
the
relays
that
year,
but
I
did
raise
money.
D
I
lived
in
Tennessee
and
sent
my
money
up
to
the
Westerly
Rhode
Island
Relay
for
Life
the
next
year
same
person
asked
me
to
be
on
the
team
again
so
I
said:
okay
I
raised
money
in
Tennessee
this
year,
I
came
up
and
I
wanted
to
be
a
participant
in
the
Relay
for
Life
I
got
there
set
up
my
tent
set
up.
My
fundraiser
I
listened
to
opening
ceremonies,
and
then
I
watched
the
survivor,
lap
and
I
was
so
angry.
I
was
so
angry
that
my
dad
was
not
walking
on
that
track.
D
I
thought
it
was
so
unfair
that
all
these
people
were
walking
the
track,
but
not
my
dad
and
then
I
watched,
more
survivors,
walk
by
me
and
more
survivors
and
I
literally
fell
to
my
knees.
Sobbing
I
was
so
full
of
hope
at
that
moment,
seeing
all
those
people
who
had
survived
walking
the
track
and
at
that
moment
I
knew
that
I
was
going
to
do
everything
possible
to
make
sure
that
there
were
more
survivors
and
more
survivors,
I.
D
D
Ten
years
after
my
father
passed
away,
I
was
diagnosed
with
cervical
cancer.
My
cancer
was
caught
early
due
to
a
simple
pap
smear,
supported
by
research
funded
by
the
American
Cancer
Society.
Just
like
the
one
who
we're
hearing
from
this
morning,
dr.
Hebert
the
wave3
actually
works.
It
was
caught
early.
It
was
treated
successfully
all
because
the
American
Cancer
Society
taught
me
that
having
annual
exams
was
very
important,
I
knew
I
went
religiously
every
year,
had
I
not
done
that
it
would
not
have
been
caught
early,
it
would
not
have
been
treated
successfully.
D
This
was
a
second
time
the
American
Cancer
Society
saved
my
life.
I
have
been
so
fortunate
to
fight
alongside
as
the
American
Cancer
Society
and
the
Cancer
Action
Network
I'm,
so
grateful
for
all
the
opportunities
that
I've
had
through
the
American
Cancer
Society
and
the
Cancer
Action
Network
I
owe
my
life
to
the
American
Cancer,
Society
and
I'm,
going
to
fight
until
no
other
daughter
has
to
lose
her
father
I'm
going
to
fight
until
no
one
has
to
hear
those
words,
you
have
cancer,
your
loved
one
has
cancer.
D
D
There
are
some
petitions
on
your
tables
and
we'd
like
for
you
to
look
at
those
and
sign
those.
We
want
to
increase
funding
for
cancer
research
so
important
again.
My
cancer
was
caught
because
of
that
research
was
caught
early.
We
need
to
find
more
ways
to
catch
cancer,
to
treat
cancer
and
to
cure
cancer.
So
if
you'd
please
join
me
and
find
those
petitions
petitions,
I
would
really
be
grateful.
Thank
you.
A
J
Thank
You
Meredith
I'd
like
to
add
my
personal
thanks
to
all
the
sponsors
and
to
all
those
in
attendance
this
morning,
both
for
your
support
of
ACS
can
and
for
this
event
in
particular,
I
also
like
to
add
my
personal
thanks
to
the
others
on
the
planning
committee.
Their
names
are
in
your
program
and
so
Shalini
vallavan
and
LexA
Sullivan
from
ACS
Ken,
who
did
a
lot
of
the
hard
work
to
pull
this
program
together.
So
thank
you
all.
Over.
J
This
was
very
clear
to
me
at
the
outset,
then,
given
their
important
role
through
innovation,
advocacy
in
Seoul
and
broad
ujin's,
Henry
and
Melinda
Tahrir
would
be
ideal.
People
to
honor
in
this
way
and
the
Planning
Council
in
ACS
can
agreed
having
known
Henry
and
Belinda's
for
over
20
years
and
having
worked
for
Henry
at
Genzyme
for
15
years,
I'm
milking
forward
pondering
them
today.
So
this.
J
His
passing
was
a
tremendous
loss
to
so
many
many
of
us
directly
benefited
from
his
friendship
and
mentorship,
and
so
many
more
benefited
from
the
results
of
extraordinary
efforts
to
bring
forward
novel
therapies
that
have
dramatically
improved
the
lives
of
thousands
of
patients
and
their
families.
Our
five,
the
best
wishes
go
out
to
Belinda
to
their
daughter,
Adriana,
son,
Nikolas
and
the
entire
family,
and
we're
very
pleased
that
Belinda
and
Adriana
are
joining
us
this
morning.
J
Many
as
Belinda
and
Henry's
accomplishments
are
summarized
in
your
program,
but
I
do
want
to
highlight
a
few
Belinda
and
Henry
are
widely
recognized
for
their
efforts,
both
together
and
individually,
to
make
the
world
a
better
place.
These
efforts
have
ranged
from
health
care
and
science
and
medicine
to
education,
equal
opportunity,
human
rights,
they've
been
members,
supporters
and
board
members
of
WGBH
of
the
Boston
Ballet
and
the
Boz
museum
of
science
with
respect
to
their
work
in
fight
against
cancer.
J
Together
they
look,
they
launched
the
Henry
and
Melinda
tour,
mirror
Center
for
targeted
therapies
that
mess
general
to
speed
the
discovery
and
delivery
of
new
targeted
therapies
to
patients
with
cancer.
They
also
founded
the
Henry
and
Melinda
career
early
career
investigators,
fellowship
to
foster
collaboration
between
physician
scientists,
with
joint
appointments
at
Mass
General
and
the
Harvard
Medical
School
laboratory
systems
pharmacology.
This
idea
of
collaboration
is
one
that
was
very
important
to
Henry
and
you'll
see.
It
is
recurrent
theme
Melinda.
J
J
Venture
one
of
the
world's
leading
biotechnology
companies
developing
Transformus
medicines
that
had
dramatically
improve
the
lives
of
patients
suffering
from
rare
genetic
diseases
from
raised
renal
diseases,
multiple
sclerosis,
orthopedic
disorders,
burns
and
cancer.
Henry
received
many
honors
and
awards
over
the
years,
but
I
just
like
to
highlight
a
few.
In
1999
he
was
named
a
fellow
of
the
American
Academy
of
Arts
and
Sciences
in
2005
on
behalf
of
Genzyme
Henry
accepted
the
National
Medal
of
Technology
and
innovation,
the
highest
highest
honor
awarded
by
the
President
of
the
United
States
for
technological
innovation.
J
Also,
a
2005
Henry
was
elected
to
honorary
fellowship
in
the
Royal
is
a
British
Royal
College
of
Physicians,
an
honor
I
suspect,
is
pretty
unusual
for
an
economist
and
entrepreneur
and
reserves
on
the
boards
directors
of
several
biotech
companies
and
advised
many
more.
However,
his
insights
were
also
sought.
After
in
the
not-for-profit
world,
he
was
a
member
of.
C
J
J
J
And
guidance
needed
for
successful
careers
in
medical
science
in
2002
Henry
was
the
driving
force
behind
founding
of
nehi
than
doing
late.
Healthcare
Institute
more
recently,
renamed
the
network
for
excellence
in
healthcare.
Innovation
nehi
is
a
highly
regarded
nonpartisan
research
and
policy
organization
dedicated
to
finding
innovative
solutions
to
urgent
health
care
problems.
J
It
was
founded
on
the
belief
that
changing
healthcare
requires
leadership,
vision
and,
again
importantly,
collaboration
Henry
led
the
charge
to
bring
together
a
number
of
high-profile
health
care
leaders
from
academia
from
biotech
from
Pharma
from
our
hospital
systems
and
from
our
payers.
These
included
people
like
Jill
Martin,
with
the
time
of
the
Dean
of
Harvard
Medical
School
Sam
seer,
who
then
the
CEO
of
Partners
HealthCare
and
a
CEO
of
Harvard
Pilgrim
health
care
guy
named
Charlie
Baker.
C
J
Do
so,
no
matter
how
difficult
he
always
made
it
very
clear
that
everything
we
did
must
center
around
doing
better
by
patients.
That
was
our
responsibility.
He
brought
together
smart
people,
he
fostered
multidisciplinary
team
work
and
collaboration,
the
focus
always
being
undoubtedly
rapidly,
but
responsibly
new
treatments
to
help
patients.
We
all
believed
in
this
mission
and
we're
all
very
proud
to
be
a
part
of
it.
Henry
is
also
very
generous
at
this
time
on
the
individual
level.
J
J
J
Hebert
describes
several
recent
breakthroughs
in
cancer
treatments
and
notice
that
we
now
know
more
about
the
origins
of
many
cancers
and,
more
importantly,
we
now
have
the
tools
to
allow
us
to
learn
even
more,
to
develop
more
effective
treatments
shall
I
fetch,
allottee
and
I
discussed
ATS
Ken's
advocacy
priors,
particularly
around
not
only
stopping
the
proposed
health
care
cuts
that
you
heard
about,
but
putting
for
additional
funds
to
allow
work
on
the
cancer
moonshot
initiative
to
proceed
and
expeditiously
as
possible.
Henry
has
been
a
longtime
strong
supporter
of
funding
for
the
NIH
and
NCI.
J
He
appreciated
the
importance
of
collaboration
between
researchers
and
academia
to
create
new
discoveries
and
industry
to
advance
those
discoveries
and
bring
the
medicines
forward.
It
was
clear
to
Henry
and
Melinda
at
that
meeting
that
now
had
the
tools
to
advance
the
field
and
again
this
opportunity
then
created
a
responsibility
and
Henry
said
several
times
during
that
meeting.
Now
is
the
moment
I
think
he
intended
to
share
that
message
this
morning.
He
said
we
need
to
set
bold
goals
and
we
must
find
ways
to
dramatic
the
advanced
research
and
to
finish
the
fight.
J
We
don't
have
any
other
choice.
Now
is
the
moment
during
a
subsequent
phone
call
early
may
I
asked
Henry.
If
there
was
anything
you
wanted
me
to
say
when
I
introduced
in
the
scoring,
he
only
said
and
I
quote,
we
only
wanted
to
do
stuff
that
had
an
impact
that
makes
a
difference
stuff
that
translates
that
helps
patients
clearly.
J
That
goal
he
made
contributions
that
will
live
on
forever
and
the
deed
will
continue
to
grow
through
the
contributions
of
the
legions
he
mentored
and
through
the
contributions
of
the
thousands
of
patients
with
god,
lead
productive
lives
because
of
the
transformative
medicines.
He
played
a
role
in
developing
I'd.
J
And
Adriana
career
to
come
forward
to
accept
this
war,
which
honors
both
Belinda's
and
Henry's
work.
It
reads:
the
American
Cancer
Society,
Cancer,
Action,
Network
greatly
right,
gracefully,
recognizes
Henry
and
Melinda
premier
for
your
leadership
and
passion
to
catalyze
cancer,
research
and
innovation,
June
12
2007.
F
C
F
F
She
and
my
father
have
dedicated
their
lives
to
research
and
cancer
in
cancer,
a
health
care
industry,
so
that
many
other
people
can
call
themselves
survivor
to
a
countless
number
of
patients
have
been
treated
at
the
term.
Erie
Center
for
targeted
therapies
for
life-saving
treatments,
I'm
so
incredibly,
incredibly
proud
that
they
have
made
this
possible
I
wish.
My
father
had
been
here
today
to
receive
his
honor
with
my
mother,
I'm
sure
that
he
would
have
loved
to
see
some
of
those
people,
but
he
had
impacted.
She
makes
me
so
proud.
F
A
A
And
our
condolences
to
both
so
despite
our
very
speakers
and
politicians,
survivors,
researchers,
family
members,
I'm
sure
you
have
noticed
a
theme
throughout
the
remarks
this
morning
that
it
is
imperative
for
all
of
us
as
individuals,
companies,
healthcare
institutions,
to
urge
policymakers
to
protect
and
increase
federal
funding
for
cancer.
Research
not
decreases
our
ability
to
advance
the
development
of
better
treatments,
diagnostics
and
prevention.
Efforts
are
within
our
reach
and
the.
A
Pace
with
the
scientific
opportunities
that
are
clearly
within
our
grasp,
there's
no
doubt
that
there
are
strengthen
our
voices
come
together.
If
you
would
like
to
learn
more
about
the
ACS,
can
please
reach
out
to
volunteers
or
staff
in
the
room
that
has
that
listed
on
their
nametags,
and
they
want
me
to
remind
you
that
it
only
takes
a
few
seconds
to
make
sure
that
elected
officials
hear
your
voice
by
signing
a
petition
on
your
table,
asking
Congress
to
increase
federal
research
funding.
A
Don't
forget
to
share
with
your
colleagues
and
friends
about
this
important
issue,
because
it's
2017,
you
can
always
find
us
on
social
media
and
tweet
post
and
otherwise
share
anything
valuable
that
you
learn
today
on
behalf
of
the
American
Cancer
Society
and
ACS.
Can
our
thanks
go
to
all
of
our
speakers
and
the
response
then
go
out
to
each
and
every
one
of
you
for
your
support,
your
generosity
and
your
commitment
to
more
cancer
research.
Thank
you
for
having
me
be
here
with
you
this
morning
have
a
great
day
and
a
great
rescue.